SARS-CoV-2 vaccination in solid-organ transplant recipients

M Peghin, E Graziano, PA Grossi - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global
challenges for solid organ transplant (SOT) recipients. Mortality rates of COVID-19 in this …

Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review

RI Hausinger, Q Bachmann, T Crone-Rawe… - Vaccines, 2023 - mdpi.com
Background: Kidney transplant recipients (KTRs) who have a highly impaired immune
response are in need of intensified and safe vaccination strategies to achieve …

[HTML][HTML] Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose

WA Werbel, AH Karaba, TPY Chiang, AB Massie… - American Journal of …, 2023 - Elsevier
Kidney transplant recipients (KTRs) show poorer response to SARS-CoV-2 mRNA
vaccination, yet response patterns and mechanistic drivers following third doses are ill …

Relationship between immune response to severe acute respiratory syndrome coronavirus 2 vaccines and development of breakthrough infection in solid organ …

C Bonazzetti, B Tazza, D Gibertoni… - Clinical Infectious …, 2023 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in
solid organ transplant (SOT) recipients is associated with poorer antibody response (AbR) …

mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study

AH Lerner, P Arvanitis, K Vieira, EJ Klein… - Open Forum …, 2022 - academic.oup.com
Abstract Background Organ transplant recipients (OTRs) are less protected from vaccination
than immunocompetent hosts. Additional vaccine doses have shown increased …

Incidence and severity of COVID-19 in relation to anti-receptor-binding domain IgG antibody level after COVID-19 vaccination in kidney transplant recipients

AL Messchendorp, JSF Sanders, AC Abrahams… - Viruses, 2024 - mdpi.com
Kidney transplant recipients (KTRs) elicit an impaired immune response after COVID-19
vaccination; however, the exact clinical impact remains unclear. We therefore analyse the …

[HTML][HTML] Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough …

A Han, S Min, EA Jo, H Lee, YC Kim… - Annals of laboratory …, 2024 - synapse.koreamed.org
Background Whether anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibody levels post-third coronavirus disease (COVID-19) vaccination correlate with worse …

Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST …

C Bonazzetti, B Tazza, D Gibertoni, Z Pasquini… - CLINICAL INFECTIOUS …, 2023 - cris.unibo.it
Background: SARS-CoV-2 vaccination in solid organ transplant (SOT) is associated with
poorer antibody response (AbR) compared to non-SOT recipients. However, its impact on …

Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and …

JL Alejo, JD Kim, TPY Chiang, RK Avery… - Clinical …, 2023 - Wiley Online Library
Abstract Background Tixagevimab and Cilgavimab (T+ C) is authorized for pre‐exposure
prophylaxis (PrEP) against Coronavirus Disease 2019 (COVID‐19) in solid organ transplant …

[HTML][HTML] New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses

H Kang, EJ Oh - Annals of Laboratory Medicine, 2024 - synapse.koreamed.org
Over the past four years, the world has experienced an unprecedented pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accordingly, the …